XML 89 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
2021 Stock incentive Plan    
Options Outstanding    
Outstanding, beginning balance (in shares) 10,283,771  
Granted (in shares) 0 0
Exercised (in shares) (5,477,153)  
Canceled (in shares) (235,597)  
Outstanding, ending balance (in shares) 4,571,021 10,283,771
Vested & expected to vest, awards outstanding (in shares) 4,571,021  
Exercisable, awards outstanding (in shares) 4,405,278  
Weighted Average Exercise Price    
Outstanding, beginning balance (in USD per share) $ 4.18  
Granted (in USD per share) 0  
Exercised (in USD per share) 3.29  
Canceled (in USD per share) 7.58  
Outstanding, ending balance (in USD per share) 5.08 $ 4.18
Vested & expected to vest, weighted average exercise price (in USD per shares) 5.08  
Exercisable, weighted average exercise price (in USD per share) $ 4.96  
Outstanding, weighted average remaining contractual term 3 years 2 months 23 days 6 years 4 months 17 days
Outstanding, aggregate intrinsic value $ 44,309 $ 66,234
Vested & expected to vest, weighted average remaining contractual term 3 years 2 months 23 days  
Vested & expected to vest, aggregate intrinsic value $ 44,309  
Exercisable, weighted average remaining contractual term 3 years 2 months 23 days  
Exercisable, aggregate intrinsic value $ 43,157  
Amended and Restated 2010 Equity Incentive Plan | Performance-Based Awards    
Options Outstanding    
Outstanding, beginning balance (in shares) 50,000  
Granted (in shares) 0  
Exercised (in shares) 0  
Canceled (in shares) 0  
Outstanding, ending balance (in shares) 50,000 50,000
Vested & expected to vest, awards outstanding (in shares) 50,000  
Exercisable, awards outstanding (in shares) 26,041  
Weighted Average Exercise Price    
Outstanding, beginning balance (in USD per share) $ 3.06  
Granted (in USD per share) 0  
Exercised (in USD per share) 0  
Canceled (in USD per share) 0  
Outstanding, ending balance (in USD per share) 3.06 $ 3.06
Vested & expected to vest, weighted average exercise price (in USD per shares) 3.06  
Exercisable, weighted average exercise price (in USD per share) $ 3.06  
Outstanding, weighted average remaining contractual term 4 years 6 months 29 days 5 years 6 months 29 days
Outstanding, aggregate intrinsic value $ 584 $ 375
Vested & expected to vest, weighted average remaining contractual term 4 years 6 months 29 days  
Vested & expected to vest, aggregate intrinsic value $ 584  
Exercisable, weighted average remaining contractual term 4 years 6 months 29 days  
Exercisable, aggregate intrinsic value $ 304